Two Sigma Securities’s BioCardia BCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.9K Buy
+14,780
New +$18.5K ﹤0.01% 1389
2025
Q4
Sell
-19,337
Closed -$24.9K 1483
2025
Q3
$24.9K Buy
+19,337
New +$37.8K ﹤0.01% 1097
2024
Q2
Sell
-7,405
Closed -$45.2K 2981
2024
Q1
$45.2K Buy
+7,405
New +$53.1K ﹤0.01% 2577
2022
Q1
Sell
-1,413
Closed -$41K 2111
2021
Q4
$41K Buy
+1,413
New +$51.8K ﹤0.01% 1304

Other funds holding BCDA

Two Sigma Securities's BCDA Position: Q1 2026 in Review

Two Sigma Securities opened a new position in BioCardia (BCDA) in Q1 2026: 14,780 shares worth $17.9K. The stake represents ﹤0.01% of the portfolio and ranks #1389 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in BCDA as recently as Q3 2025.

Two Sigma Securities first reported a position in BCDA in Q4 2021 and has held it in 4 quarters since. The position peaked at $45.2K in Q1 2024. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

  • Two Sigma Securities held 14,780 shares of BioCardia worth $17.9K as of Q1 2026.
  • BioCardia was a new Two Sigma Securities position in Q1 2026.
  • BioCardia made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1389 holding.
  • Two Sigma Securities first reported a position in BioCardia in Q4 2021 and has held it in 4 quarters since.
  • Two Sigma Securities's BioCardia position peaked at $45.2K in Q1 2024.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.